HIRA anticorps (pThr555)
Aperçu rapide pour HIRA anticorps (pThr555) (ABIN7181414)
Antigène
Voir toutes HIRA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pThr555
-
Réactivité croisée
- Humain, Souris
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from Human HIRA around the phosphorylation site of T555.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:10000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- HIRA (HIR Histone Cell Cycle Regulation Defective Homolog A (HIRA))
-
Autre désignation
- HIRA
-
Sujet
- DGCR1 antibody, DiGeorge critical region gene 1 antibody, HIR antibody, HIR histone cell cycle regulation defective homolog A antibody, HIRA antibody, HIRA protein antibody, HIRA_HUMAN antibody, Histone cell cycle regulator antibody, Protein HIRA antibody, TUP 1 antibody, TUP1 like enhancer of split protein 1 antibody, TUP1-like enhancer of split protein 1 antibody, TUPLE1 antibody
-
UniProt
- P54198
-
Pathways
- Chromatin Binding
Antigène
-